SEC Form 4 · accession 0001520262-26-000110
Alkermes plc. · ALKS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Craig C. Hopkinson
Officer — EVP R&D, Chief Medical Officer
Period of report
Aug 3, 2026
Accepted (ET)
Aug 3, 2026 · 7:12 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001520262
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Aug 3, 2026 | M | 104 | $19.34 | A | 73,493 | D | |
| Ordinary Shares | Aug 3, 2026 | M | 4,896 | $24.59 | A | 78,389 | D | |
| Ordinary Shares | Aug 3, 2026 | S | 9,000 | $48.58 | D | 69,389 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F3 | $19.34 | Aug 3, 2026 | M | 104 | D | — | Feb 22, 2031 | Ordinary Shares | 104 | 1,252 | D |
| Employee Stock Option (Right to Buy)F3 | $24.59 | Aug 3, 2026 | M | 4,896 | D | — | Feb 18, 2032 | Ordinary Shares | 4,896 | 66,276 | D |
Explanation of responses
- F1This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025.
- F2This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025.
- F3These options are fully vested in accordance with their terms.